Biotech is one of the most potentially lucrative yet endlessly frustrating market sectors. Last year was particularly annoying. There were a couple big wins in the space, but the entire industry has been kneecapped for a few reasons… First, the post-COVID hangover is still there, and it’s tough to get patients for testing. Second, the […]